Skip to Main Content

Paper Details

Rationale and design of the Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE).
Am Heart J
99
2019
AIDS, ASCVD, CVD, Cardiovascular disease, HIV, HIV-infected, LDL-C, MACE, PWH, Participants, atherosclerotic cardiovascular disease, cholesterol, low-density lipoprotein cholesterol, participants, people, pitavastatin calcium, statin
Author NameAffiliation
Carl J FichtenbaumUniversity of Cincinnati College of Medicine
Judith S CurrierDavid Geffen School of Medicine at University of California Los Angeles
Judith S CurrierDavid Geffen School of Medicine at University of California Los Angeles
Heather J RibaudoCenter for Biostatistics in AIDS Research, Harvard TH Chan School of Public Health
Pamela S DouglasDuke Clinical Research Institute, Duke University School of Medicine
  • 1 - 5

Datasets

Release 1.2